ES2179333T3 - Composicion para diagnosis. - Google Patents

Composicion para diagnosis.

Info

Publication number
ES2179333T3
ES2179333T3 ES97922232T ES97922232T ES2179333T3 ES 2179333 T3 ES2179333 T3 ES 2179333T3 ES 97922232 T ES97922232 T ES 97922232T ES 97922232 T ES97922232 T ES 97922232T ES 2179333 T3 ES2179333 T3 ES 2179333T3
Authority
ES
Spain
Prior art keywords
stomach
diagnosis
composition
lapreparation
amoniac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97922232T
Other languages
English (en)
Inventor
Christer Nystrom
Anders Pettersson
Thomas Lundqvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diabact AB
Original Assignee
Diabact AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diabact AB filed Critical Diabact AB
Application granted granted Critical
Publication of ES2179333T3 publication Critical patent/ES2179333T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Atmospheric Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Endoscopes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PREPARADO SUSTANCIAL LIBRE DE AGUA PARA ADMINISTRAR UREA EN FORMA DE PASTILLA, CAPSULA U CUALQUIER OTRA FORMA SOLIDA. EL PREPARADO SE DISUELVE MUY RAPIDAMENTE EN EL ESTOMAGO. LAPREPARACION SE UTILIZA PARA DEMOSTRAR LA PRESENCIA DE AMONIACO EN EL AIRE DE EXHALACION, DERIVADO DE LA ACTIVIDAD DE UREASA AUMENTADA EN EL ESTOMAGO EN UNION CON UNA INFECCION EXISTENTE POR HELICOBACTER PYLORI.
ES97922232T 1996-04-30 1997-04-18 Composicion para diagnosis. Expired - Lifetime ES2179333T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601659A SE9601659D0 (sv) 1996-04-30 1996-04-30 Diagnostisk läkemedelsberedning

Publications (1)

Publication Number Publication Date
ES2179333T3 true ES2179333T3 (es) 2003-01-16

Family

ID=20402411

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97922232T Expired - Lifetime ES2179333T3 (es) 1996-04-30 1997-04-18 Composicion para diagnosis.

Country Status (17)

Country Link
EP (1) EP0896547B1 (es)
JP (1) JP4091660B2 (es)
CN (1) CN1102411C (es)
AT (1) ATE219689T1 (es)
AU (1) AU721317B2 (es)
BG (1) BG63036B1 (es)
BR (1) BR9709179A (es)
CA (1) CA2252399C (es)
DE (1) DE69713588T2 (es)
DK (1) DK0896547T3 (es)
EE (1) EE03808B1 (es)
ES (1) ES2179333T3 (es)
HU (1) HU226656B1 (es)
NZ (1) NZ332514A (es)
PL (1) PL187098B1 (es)
SE (1) SE9601659D0 (es)
WO (1) WO1997040856A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
US7087398B2 (en) 2001-10-15 2006-08-08 Marshall Barry J Method for detecting urease
US6929926B2 (en) 2001-10-15 2005-08-16 Barry J. Marshall Composition for the detection of gastrointestinal disorders
KR20040047878A (ko) * 2001-10-15 2004-06-05 킴벌리-클라크 월드와이드, 인크. 우레아제 검출용 시스템 및 그 사용 방법
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing
WO2007013409A1 (ja) * 2005-07-25 2007-02-01 Otsuka Pharmaceutical Co., Ltd. ピリジン代謝能の測定に有用な経口製剤
WO2014030650A1 (ja) 2012-08-20 2014-02-27 大塚製薬株式会社 糖代謝能の測定方法及びそれに使用する組成物
EP2975400B1 (en) 2013-03-15 2019-09-04 Otsuka Pharmaceutical Co., Ltd. Composition for use in a method for measuring sugar/fatty acid combustion ratio

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161428C (da) * 1985-05-10 1991-12-16 Fertin Lab As Fast, oralt cariesmodvirkende middel
US4947861A (en) * 1989-05-01 1990-08-14 Hamilton Lyle H Noninvasive diagnosis of gastritis and duodenitis
CN1137732C (zh) * 1993-10-28 2004-02-11 巴瑞·马休 胃内幽门螺杆菌的检测
SE503522C2 (sv) * 1994-10-31 1996-07-01 Ericsson Telefon Ab L M Förfarande och anordning för kanalestimering
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken

Also Published As

Publication number Publication date
DE69713588T2 (de) 2002-10-10
BR9709179A (pt) 2000-01-11
SE9601659D0 (sv) 1996-04-30
EP0896547B1 (en) 2002-06-26
HUP0002204A3 (en) 2005-11-28
EE9800364A (et) 1999-04-15
WO1997040856A1 (en) 1997-11-06
NZ332514A (en) 2000-04-28
HUP0002204A2 (hu) 2000-11-28
CA2252399C (en) 2008-08-12
CN1102411C (zh) 2003-03-05
EP0896547A1 (en) 1999-02-17
AU2795697A (en) 1997-11-19
AU721317B2 (en) 2000-06-29
CN1216924A (zh) 1999-05-19
ATE219689T1 (de) 2002-07-15
BG63036B1 (bg) 2001-02-28
PL187098B1 (pl) 2004-05-31
DK0896547T3 (da) 2002-10-21
HU226656B1 (en) 2009-06-29
EE03808B1 (et) 2002-08-15
DE69713588D1 (de) 2002-08-01
JP4091660B2 (ja) 2008-05-28
BG102953A (bg) 1999-07-30
PL329621A1 (en) 1999-03-29
JP2001500843A (ja) 2001-01-23
CA2252399A1 (en) 1997-11-06

Similar Documents

Publication Publication Date Title
ES2214753T3 (es) Uso de 9-desoxi-2',9-alfa-metano-3-oxa-4,5,6-trinor-3,7-(1',3'-interfenilen)-13,14-dihidro-prostaglandina f1 para tratar la enfermedad vascular periferica.
ES2179333T3 (es) Composicion para diagnosis.
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
CY1109172T1 (el) Δισκιο για παρειακη, υπογλωσσια ή ουλαια χορηγηση, που περιεχει ενα αναβραζουν ζευγος
KR970706830A (ko) 2, 2'-디티오-비스(에탄설포네이트)(디메스나)와 조합된 시스플라틴의 조성물(composition of cisplatin in combination with 2, 2＇-dithio-bis (ethanesulfonate) (dimesna)
ES2168241T1 (es) Preparacion farmaceutica que contiene tolperisona para administrar por via oral.
AR036937A1 (es) Tableta masticable que contiene lisina
BG103005A (en) Active substance-containing sedimented silicic acids
ES2119818T3 (es) Preparacion oral para liberacion en el tracto digestivo inferior.
ATE303137T1 (de) Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit
PE20030830A1 (es) Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea
EP0194336A3 (en) Oral mobenzoxamine preparation
ES2176009T3 (es) Utilizacion de cloruro de sodio para reducir la toxicidad gastrointestinal de los derivados de la competencia.
KR870009716A (ko) 클로르페니라민 제형
AR022338A1 (es) Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
CO5180574A1 (es) Micofenolato mofetil en asociacion con peg-inf-a
IT8421874A0 (it) Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno.
ATE165239T1 (de) Orale arzeimittelzubereitung enthaltend diclofenac-natrium und eine organische säure
BR9506507A (pt) Forma galênica de derivados de 5-nitro-imadazol composiçoes farmacêuticas microgrânulos gastro-protegidos de derivados de 5-nitro-imidazol e produto da combinaçao
ATE74523T1 (de) Praeparat zur intramuskulaeren injektion von medikamenten, vitaminen oder impfstoffen.
ES2038658T3 (es) Una formulacion farmaceutica conteniendo indometacina.
DE60112578D1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
ATE231391T1 (de) Orale pharmazeutische zubereitung enthaltend paracetamol und metoclopramid